← Leaderboards
Darrick Albert Carter
Pai Life Sciences, Inc.
$10,984,674
Attributed
$16,395,474
Total exposure
16
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,152,474 · 15
CDC$243,000 · 1
By mechanism
R44$13,639,874 · 5
R43$2,221,363 · 9
R21$376,836 · 1
R41$157,401 · 1
Top collaborators
- Afzal A Siddiqui8 shared
- Ramaswamy Kalyanasundaram6 shared
Most similar at Pai Life Sciences, Inc.
Same institution · by research overlap
- Adebayo J Molehin$147,693
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsGlobal HealthFutureAntigensPharmaceutical PreparationsClinical TrialsCountryAdjuvantInfectionPre-ClinicalVaccinesParasitesProgramsNonhuman PrimateCyclic GmpAnimal ModelTransmission ProcessAgonistPathologyDisease TransmissionSafetyCellsFermentationProphylactic
Grant awards (30)
A Vaccine for Lymphatic Filariasis, LFGuardâ¢$452,996
R44 · FY2025 · AI · contact PI
A Vaccine for Lymphatic Filariasis, LFGuardâ¢$995,460
R44 · FY2024 · AI · contact PI
A Vaccine for Lymphatic Filariasis, LFGuardâ¢$1,000,000
R44 · FY2022 · AI · contact PI
A Vaccine for Schistosomiasis, "SchistoShield"$506,495
R44 · FY2022 · AI · contact PI
A Vaccine for Lymphatic Filariasis, LFGuardâ¢$1,000,000
R44 · FY2021 · AI · contact PI
A Vaccine for Schistosomiasis, "SchistoShield"$506,495
R44 · FY2021 · AI · contact PI
Adjuvanted Recombinant Candidates to Prime / Boost COVID-19 RNA Vaccines$243,000
R43 · FY2021 · IP · contact PI
Developing a Screen for New Adjuvants to Enhance RNA Vaccines$86,791
R21 · FY2021 · AI · contact PI
A Vaccine for Lymphatic Filariasis, LFGuardâ¢$1,000,000
R44 · FY2020 · AI · contact PI
A Vaccine for Schistosomiasis, "SchistoShield"$706,627
R44 · FY2020 · AI · contact PI
JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer$556,615
R44 · FY2020 · CA · contact PI
Developing a Screen for New Adjuvants to Enhance RNA Vaccines$290,045
R21 · FY2020 · AI · contact PI
JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer$720,945
R44 · FY2019 · CA · contact PI
Process Development for a Lymphatic Filariasis Vaccine, (LFGuardâ¢)$224,988
R43 · FY2019 · AI · contact PI
A Vaccine for Schistosomiasis, "SchistoShield"$1,288,089
R44 · FY2018 · AI · contact PI
A Vaccine for Schistosomiasis, "SchistoShield"$1,380,664
R44 · FY2017 · AI · contact PI
CruziScreen, a recombinant antigen-based screening test for Chagas disease$157,401
R41 · FY2017 · AI · contact PI
A Vaccine for Schistosomiasis, "SchistoShield"$1,159,786
R44 · FY2016 · AI · contact PI
A recombinant protein that increases engraftment of hematopoietic stem cells$208,639
R43 · FY2016 · HL · contact PI
JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer$199,997
R43 · FY2016 · CA · contact PI
Reducing Complement Inhibition to Treat Leukemia and Lymphoma$812,715
R44 · FY2014 · CA · contact PI
Process Development on a Schistosomiasis Vaccine, SchistoShield???$300,000
R43 · FY2014 · AI · contact PI
Tumor Tight Junction Opener + Chemotherapy Conjugates to Treat Cancer$191,159
R43 · FY2014 · CA · contact PI
Reducing Complement Inhibition to Treat Leukemia and Lymphoma$833,191
R44 · FY2013 · CA · contact PI
Process Development on a Schistosomiasis Vaccine, SchistoShield???$300,000
R43 · FY2013 · AI · contact PI
Reducing Complement Inhibition to Treat Leukemia and Lymphoma$300,000
R43 · FY2011 · CA · contact PI
Developing a new leprosy diagnostic test$340,170
R44 · FY2009 · AI · contact PI
Developing a new rapid test for human African trypanosomiasis$153,580
R43 · FY2009 · AI · contact PI
Developing a new leprosy diagnostic test$379,626
R44 · FY2008 · AI · contact PI
Developing a new leprosy diagnostic test$100,000
R43 · FY2007 · AI · contact PI